Novel diagnostic tools to measure retinal function and structure are rapidly being developed and introduced into clinical use. Opportunities exist to use these informative and robust measures as endpoints for clinical trials to determine efficacy and to monitor safety of therapeutic interventions. In order to inform researchers and clinician-scientists about these new diagnostic tools, a workshop was organized by the European Vision Institute. Invited speakers highlighted the recent advances in state-of-the-art technologies for outcome measures in the field of retina. This review highlights the workshop's presentations in the context of published literature
Multiple gene therapy trials are occurring for a variety of ophthalmic diseases around the world. Th...
Background: Ophthalmology is the most technologydriven specialty among all the medical specialties. ...
International audiencePurpose: To describe the value of integrating phenotype/genotype data, disease...
Glaucoma is the leading cause of irreversible blindness worldwide, with an increasing prevalence. Th...
Current diagnostic and therapeutic decisions based on the outcomes of imaging technologies have beco...
To identify patient-reported outcomes (PROs) and other clinical outcome measures (contrast sensitivi...
Introduction: Retinal imaging is a key investigation in ophthalmology. New devices continue to be c...
The horizon scanning review aimed to identify new and emerging technologies in development that have...
Photoreceptors at the back of the eye are the first step in producing our sense of vision, able to c...
To discuss and evaluate new technologies for a better diagnosis of corneal diseases and limbal stem ...
Trials of new compounds (e.g., protein kinase C inhibitors) for the treatment of diabetic ret-inopat...
The black void behind the pupil was optically impenetrable before the invention of the ophthalmoscop...
Background: Ophthalmology is the most technologydriven specialty among all the medical specialties...
Modern technologies for retinal scanning and imaging: an introduction for the biomedical enginee
Major advances in diagnostic technologies are offering unprecedented insight into the condition of t...
Multiple gene therapy trials are occurring for a variety of ophthalmic diseases around the world. Th...
Background: Ophthalmology is the most technologydriven specialty among all the medical specialties. ...
International audiencePurpose: To describe the value of integrating phenotype/genotype data, disease...
Glaucoma is the leading cause of irreversible blindness worldwide, with an increasing prevalence. Th...
Current diagnostic and therapeutic decisions based on the outcomes of imaging technologies have beco...
To identify patient-reported outcomes (PROs) and other clinical outcome measures (contrast sensitivi...
Introduction: Retinal imaging is a key investigation in ophthalmology. New devices continue to be c...
The horizon scanning review aimed to identify new and emerging technologies in development that have...
Photoreceptors at the back of the eye are the first step in producing our sense of vision, able to c...
To discuss and evaluate new technologies for a better diagnosis of corneal diseases and limbal stem ...
Trials of new compounds (e.g., protein kinase C inhibitors) for the treatment of diabetic ret-inopat...
The black void behind the pupil was optically impenetrable before the invention of the ophthalmoscop...
Background: Ophthalmology is the most technologydriven specialty among all the medical specialties...
Modern technologies for retinal scanning and imaging: an introduction for the biomedical enginee
Major advances in diagnostic technologies are offering unprecedented insight into the condition of t...
Multiple gene therapy trials are occurring for a variety of ophthalmic diseases around the world. Th...
Background: Ophthalmology is the most technologydriven specialty among all the medical specialties. ...
International audiencePurpose: To describe the value of integrating phenotype/genotype data, disease...